Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For UCBIO
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Bad
0%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -78.20 -154.56 709.10
Graham Fair Price 111.99 18.02 8.50
PEG -96.16 0.03 -0.86
Price/Book -14.54 0.92 1.07
Price/Cash Flow -90.90 37.72 414.33
Prices/Earnings -80.55 12.08 62.10
Price/Sales -27.31 8.06 11.09
Price/FCF -90.90 37.72 414.33
Naive Interpretation member
01 - Valuation · Somewhat Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -28.77 0.71 1.00
Operating Margin 102931.00 0.25 < 0.005
ROA 343.41 < 0.005 < 0.005
ROE < 0.005 0.02 339.31
ROIC < 0.005 0.02 74484.55
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ < 0.005 -0.10 -99.91
Dividends QOQ 0.03 < 0.005 -98.51
EBIT QOQ -1.00 1226.65 122407.17
EPS QOQ -0.72 3.64 406.49
FCF QOQ -0.88 8.50 863.08
Revenue QOQ 0.38 0.19 -49.65
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) 25.03 0.00 inf
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization 0.09 0.09 -4.11
Quick Ratio 0.24 0.35 44.50
Naive Interpretation member
04 - Leverage & Liquidity · Bad
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 27.27 27.58 1.14
Cash 36.24 36.40 0.43
Capex -0.11 -0.11 -2.82
Free Cash Flow 0.07 0.67 849.42
Revenue 2.64 3.14 18.91
Naive Interpretation member
05 - Per Share Metrics · Best
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 0.06 0.08 38.31
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -170.70 41.21 -75.86
Naive Interpretation Member
06 - Financial Health · Bad